Royalty Pharma
RPRX
$27.89
Share price
1.01%
Change (1 day)
-22.29%
Change (1 year)
Categories
Royalty Pharma (RPRX) - Net assets
Net assets on the balance sheet as of December 2023 : $10.08 B
According to Royalty Pharma's latest financial reports the company has $10.08 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Royalty Pharma - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $10.08 B | 5.87% |
| 2022-12-31 | $9.52 B | -7.06% |
| 2021-12-31 | $10.24 B | 3.56% |
| 2020-12-31 | $9.89 B | 61.13% |
| 2019-12-31 | $6.14 B | 34.92% |
| 2018-12-31 | $4.55 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $38.82 B | 285.02% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 7.73% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.45 B | -95.46% | 🇺🇸 USA |